2,429
Total Claims
$1.7M
Drug Cost
486
Beneficiaries
$3,420
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-33%
Cost per patient vs peers
$3,420 vs $5,138 avg
+63%
Brand preference vs peers
100.0% vs 61.4% avg
Brand vs Generic
0% generic
Brand: 1,526 claims · $1.6M
Generic: 0 claims · $0
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 41 | $535K |
| Fluticasone/Umeclidin/Vilanter | 316 | $284K |
| Budesonide/Formoterol Fumarate | 224 | $126K |
| Budesonide/Glycopyr/Formoterol | 166 | $120K |
| Alpha-1-Proteinase Inhibitor | 12 | $83K |
| Fluticasone/Vilanterol | 120 | $77K |
| Mepolizumab | 16 | $61K |
| Tiotropium Br/Olodaterol Hcl | 77 | $49K |
| Tiotropium Bromide | 77 | $48K |
| Dupilumab | 11 | $43K |
| Dupilumab | 11 | $43K |
| Tiotropium Bromide | 30 | $30K |
| Umeclidinium Brm/Vilanterol Tr | 49 | $28K |
| Umeclidinium Bromide | 54 | $25K |
| Apixaban | 25 | $17K |
Prescribing Profile
30
Unique Drugs
Patient Profile
70
Avg Age
65%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About